insights_auto
Kwa nini CMXHF imeongezeka kwa 2.22%?
Fahamu zaidichevron_right
CMXHF:OTCMKTS
CSL Ltd
US$ 123.79
arrow_upward
+2.22%(+2.69) Siku 1
15 Okt, 16:00:00 GMT -4 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya CMXHF...
Fungua
US$ 129.22
Juu
US$ 129.22
Chini
US$ 123.79
Mtaji wa soko
92.23B
Wastani wa kiasi cha mauzo
167.00
Kiasi cha mauzo ya hisa
564.00
Juu kwa wiki 52
US$ 148.36
Chini kwa wiki 52
US$ 63.84
Beta
0.56
Hisa za wawekezaji
479.88M
Idadi ya wafanyakazi
elfu 29
Fungua
US$ 129.22
Juu
US$ 129.22
Chini
US$ 123.79
Mtaji wa soko
92.23B
Wastani wa kiasi cha mauzo
167.00
Kiasi cha mauzo ya hisa
564.00
Juu kwa wiki 52
US$ 148.36
Chini kwa wiki 52
US$ 63.84
Beta
0.56
Hisa za wawekezaji
479.88M
Idadi ya wafanyakazi
elfu 29
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
ad-hoc-news.de
·
siku 1 iliyopita
CSL agrees Alentis drug deal as CSL stock has AUD 89.7 billion value
Wasifu
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994. Wikipedia
Kuhusu CSL Ltd
Afisa Mkuu Mtendaji (CEO)Paul McKenzie
Wafanyakazielfu 29
Lilianzishwa1916
Makao makuuMelbourne, Victoria, Australia
Sekta-
Tovuticsl.com